Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol vs propofol for perioperative cognitive function in laparoscopic hysterectomy
ChiCTR2600121289Phase 4Not yet recruiting
- Sponsor
- Yibin Second People's Hospital
- Start
- Mar 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fospropofol disodium in post-operative cognitive decline (POCD) (2 arms), sponsored by Yibin Second People's Hospital. Primary endpoint: Incidence of postoperative cognitive dysfunction. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2600121289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121289.